4:35PM Onyx Pharma misses by $0.26, misses on revs (ONXX) 30.37 -1.17 : Reports Q2 (Jun) loss of $0.43 per share, excluding non-recurring items, $0.26 worse than the Capital IQ Consensus Estimate of ($0.17); revenues fell 1.2% year/year to $68 mln vs the $74.6 mln consensus.